Faron Announces Presentation at ESMO Congress
Faron Pharmaceuticals Ltd. (“Faron”) Faron Announces Presentation of Bexmarilimab Data From Ongoing MATINS Trial at the European Society for Medical Oncology Congress 2021 September 9, 2021 at 7:00 am BST / 9:00 am EEST TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces the presentation of updated data from the ongoing MATINS (Macrophage Antibody